Concepedia

Kenneth M. Boy

KM

Statistics

Publications

11

Citations

285

H-Index

11

Active since

1995

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (Germany)

Kenneth M. Boy is an author at Bristol-Myers Squibb (United States) specializing in medicinal chemistry, pharmacology, and drug discovery.

ORCID

Publications per year

1995–2023

11

Publications

11

Biological Evaluation of Rationally Modified Analogs of the H-Type II Blood Group Trisaccharide. A Correlation between Solution Conformation and Binding Affinity

Alexander Wei, Kenneth M. Boy, Yoshito Kishi · Journal of the American Chemical Society · 1995 · 80 citations

, , +10

3-Thio-quinolinone maxi-K openers for the treatment of erectile dysfunction

Kenneth M. Boy, Jason Guernon, Sing‐Yuen Sit et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 42 citations

, , +2

Robust Translation of γ-Secretase Modulator Pharmacology across Preclinical Species and Human Subjects

Jeremy H. Toyn, Kenneth M. Boy, Joseph Raybon et al. · Journal of Pharmacology and Experimental Therapeutics · 2016 · 25 citations · Full text

, , +17

The discovery and evaluation of [18F]BMS-986229, a novel macrocyclic peptide PET radioligand for the measurement of PD-L1 expression and in-vivo PD-L1 target engagement

David J. Donnelly, Joon‐Young Kim, Tritin Tran et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2023 · 25 citations

, , +16

Identification and Preclinical Evaluation of the Bicyclic Pyrimidine γ-Secretase Modulator BMS-932481

Kenneth M. Boy, Jason Guernon, Dmitry Zuev et al. · ACS Medicinal Chemistry Letters · 2019 · 22 citations · Full text

, , +9

1–5 of 11